331 related articles for article (PubMed ID: 33321284)
1. Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors.
Kline A; Mattern D; Cooperman N; Williams JM; Dooley-Budsock P; Foglia R; Borys S
Int J Drug Policy; 2021 Apr; 90():103051. PubMed ID: 33321284
[TBL] [Abstract][Full Text] [Related]
2. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
[No Abstract] [Full Text] [Related]
3. Understanding the increase in opioid overdoses in New Hampshire: A rapid epidemiologic assessment.
Meier A; Moore SK; Saunders EC; McLeman B; Metcalf SA; Auty S; Walsh O; Marsch LA
Drug Alcohol Depend; 2020 Apr; 209():107893. PubMed ID: 32065941
[TBL] [Abstract][Full Text] [Related]
4. Medically treated opioid overdoses among New Jersey Medicaid beneficiaries: Rapid growth and complex comorbidity amid growing fentanyl penetration.
Crystal S; Nowels M; Olfson M; Samples H; Williams AR; Treitler P
J Subst Abuse Treat; 2021 Dec; 131():108546. PubMed ID: 34391586
[TBL] [Abstract][Full Text] [Related]
5. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
Mistler CB; Chandra DK; Copenhaver MM; Wickersham JA; Shrestha R
J Community Health; 2021 Apr; 46(2):349-357. PubMed ID: 32997253
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs.
Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF
Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143
[TBL] [Abstract][Full Text] [Related]
7. Insights from biosurveillance: non-fatal opioid overdoses in Rhode Island 2019-21.
King E; Marchetti L; Weidele H; Wolanski J; Shrestha N; St John K; Scagos R
Addiction; 2022 Sep; 117(9):2464-2470. PubMed ID: 35434861
[TBL] [Abstract][Full Text] [Related]
8. Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.
Kline A; Williams JM; Steinberg ML; Mattern D; Chesin M; Borys S; Chaguturu V
J Subst Use Addict Treat; 2023 Jun; 149():209028. PubMed ID: 37003539
[TBL] [Abstract][Full Text] [Related]
9. Predictors of intentional fentanyl use: Market availability vs consumer demand.
Foglia R; Cooperman N; Mattern D; Borys S; Kline A
Int J Drug Policy; 2021 Sep; 95():103403. PubMed ID: 34364180
[TBL] [Abstract][Full Text] [Related]
10. Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study.
Ferguson M; Choisil P; Lamb J; Burmeister C; Newman C; Lock K; Tobias S; Liu L; Buxton JA
Harm Reduct J; 2023 Dec; 20(1):178. PubMed ID: 38093272
[TBL] [Abstract][Full Text] [Related]
11. Individuals Dying of Overdoses Related to Pharmaceutical Opioids Differ from Individuals Dying of Overdoses Related to Other Substances: A Population-Based Register Study.
Skurtveit S; Odsbu I; Gjersing L; Handal M; Lid TG; Clausen T; Hamina A
Eur Addict Res; 2022; 28(6):419-424. PubMed ID: 36174536
[TBL] [Abstract][Full Text] [Related]
12. The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis.
Estadt AT; White BN; Ricks JM; Lancaster KE; Hepler S; Miller WC; Kline D
Harm Reduct J; 2024 Jan; 21(1):13. PubMed ID: 38233924
[TBL] [Abstract][Full Text] [Related]
13. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
[TBL] [Abstract][Full Text] [Related]
14. Suspected involvement of fentanyl in prior overdoses and engagement in harm reduction practices among young adults who use drugs.
Goldman JE; Krieger MS; Buxton JA; Lysyshyn M; Sherman SG; Green TC; Bernstein E; Hadland SE; Marshall BDL
Subst Abus; 2019; 40(4):519-526. PubMed ID: 31206354
[No Abstract] [Full Text] [Related]
15. Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.
Mayer S; Boyd J; Collins A; Kennedy MC; Fairbairn N; McNeil R
Drug Alcohol Depend; 2018 Dec; 193():69-74. PubMed ID: 30343236
[TBL] [Abstract][Full Text] [Related]
16. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.
Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
Harm Reduct J; 2023 Mar; 20(1):41. PubMed ID: 36978170
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of fatal opioid overdoses with stimulant involvement in Tennessee: A descriptive study using 2018 State Unintentional Drug Overdose Reporting System Data.
Korona-Bailey JA; Nechuta S; Golladay M; Moses J; Bastasch O; Krishnaswami S
Ann Epidemiol; 2021 Jun; 58():149-155. PubMed ID: 33744415
[TBL] [Abstract][Full Text] [Related]
18. Guidance for Handling the Increasing Prevalence of Drugs Adulterated or Laced With Fentanyl.
Allen C; Arredondo C; Dunham R; Fishman M; Lev L; Mace S; Parks J; Rosa D; Shoyinka S; White D; Williams A
Psychiatr Serv; 2023 Oct; 74(10):1059-1062. PubMed ID: 37042103
[TBL] [Abstract][Full Text] [Related]
19. Supply-side response to declining heroin purity: fentanyl overdose episode in New Jersey.
Hempstead K; Yildirim EO
Health Econ; 2014 Jun; 23(6):688-705. PubMed ID: 23740651
[TBL] [Abstract][Full Text] [Related]
20. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
